Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Xiang

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Clinical Genitourinary Cancer|December 6, 2021
Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder CancerMichael Xiang, Albert J Chang, Karim Chamie, et al.
JCO Oncology Practice|December 9, 2025
Fifteen-Year National Trends in Single-Fraction Stereotactic Body Radiation Therapy Utilization for Stage I Non-Small Cell Lung CancerDrew Moghanaki, Gregory Videtic, Anurag K Singh, et al.
World Neurosurgery|April 23, 2019
Prognostic Factors and Treatment Patterns in the Management of Giant Cell GlioblastomaMichael C Jin, Adela Wu, Michael Xiang, et al.
The British Journal of Radiology|May 9, 2019
Physiological motion of the optic chiasm and its impact on stereotactic radiosurgery doseMichael Xiang, Cynthia Chan, Lei Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 31, 2020
Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factorsMichael Xiang, Michael F Gensheimer, Erqi L Pollom, et al.
Development (Cambridge, England)|March 11, 2010
Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney developmentSunny Hartwig, Jacqueline Ho, Priyanka Pandey, et al.
Neuro-Oncology Practice|December 14, 2020
Impact of proton radiotherapy on treatment timing in pediatric and adult patients with CNS tumorsMichael C Jin, Siyu Shi, Adela Wu, et al.
Journal of Contemporary Brachytherapy|March 18, 2016
Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancerVinayak Muralidhar, Michael Xiang, Peter F Orio, et al.
The Medical Journal of Australia|February 27, 2015
Domestically acquired hepatitis E successfully treated with ribavirin in an Australian liver transplant recipientDavid J Speers, Michael Xiang Ma, Helen M Faddy, et al.
American Journal of Clinical Oncology|January 8, 2021
Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell CarcinomaMichael Xiang, Floyd Christopher Holsinger, Michael F Gensheimer, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Clinical Genitourinary Cancer|December 6, 2021
Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder CancerMichael Xiang, Albert J Chang, Karim Chamie, et al.
JCO Oncology Practice|December 9, 2025
Fifteen-Year National Trends in Single-Fraction Stereotactic Body Radiation Therapy Utilization for Stage I Non-Small Cell Lung CancerDrew Moghanaki, Gregory Videtic, Anurag K Singh, et al.
World Neurosurgery|April 23, 2019
Prognostic Factors and Treatment Patterns in the Management of Giant Cell GlioblastomaMichael C Jin, Adela Wu, Michael Xiang, et al.
The British Journal of Radiology|May 9, 2019
Physiological motion of the optic chiasm and its impact on stereotactic radiosurgery doseMichael Xiang, Cynthia Chan, Lei Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 31, 2020
Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factorsMichael Xiang, Michael F Gensheimer, Erqi L Pollom, et al.
Development (Cambridge, England)|March 11, 2010
Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney developmentSunny Hartwig, Jacqueline Ho, Priyanka Pandey, et al.
Neuro-Oncology Practice|December 14, 2020
Impact of proton radiotherapy on treatment timing in pediatric and adult patients with CNS tumorsMichael C Jin, Siyu Shi, Adela Wu, et al.
Journal of Contemporary Brachytherapy|March 18, 2016
Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancerVinayak Muralidhar, Michael Xiang, Peter F Orio, et al.
The Medical Journal of Australia|February 27, 2015
Domestically acquired hepatitis E successfully treated with ribavirin in an Australian liver transplant recipientDavid J Speers, Michael Xiang Ma, Helen M Faddy, et al.
American Journal of Clinical Oncology|January 8, 2021
Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell CarcinomaMichael Xiang, Floyd Christopher Holsinger, Michael F Gensheimer, et al.
Pageof 7